N@N

Law Offices of Howard G. Smith Announces Investigation On Behalf of Shareholders of MannKind Corporation

^{Published on 2010-11-05 08:41:22 - Market Wire}
 

BENSALEM, Pa.--([ BUSINESS WIRE ])--Law Offices of Howard G. Smith announces that it is investigating potential claims against MannKind Corporation (aMannKinda or the aCompanya) (NASDAQ:MNKD) concerning possible violations of securities law and/or breaches of fiduciary duty or other violations of law by the Company and its board of directors. MannKind is a biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diabetes and cancer.

The investigation concerns the Companya™s announcement that on September 16, 2010, MannKinda™s former Senior Director of Regulatory Affairs, John Arditi, filed a lawsuit in the Law Division of the Superior Court of New Jersey alleging violation of the New Jersey Conscientious Employee Protection Act, wrongful discharge, breach of contract, breach of the implied covenant of good faith and fair dealing, and intentional infliction of emotional distress. Specifically, Arditia™s lawsuit alleges he was fired for reporting to the Company possible fraud in studies for the drug, Afrezza, a diabetes drug that the United Stated Food and Drug Administration is set to rule on by the end of the year.

If you purchased shares of MannKind and still hold those shares, if you have information or would like to learn more about these claims, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to [ howardsmith@howardsmithlaw.com ], or visit our website at [ http://www.howardsmithlaw.com ].